Recent advances in the natural history of hepatocellular carcinoma

Carcinogenesis

Volumn 29, Issue 7, 2008, Pages 1299-1305

  Trevisani, Franco ^a   Cantarini, M C ^a   Wands, J R ^b   Bernardi, M ^a  

^a Azienda Ospedaliero Universitaria di Bologna   (Italy)

^b Liver Research Center Brown University Medical School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN P53; TUMOR MARKER;

AGE; ALPHA FETOPROTEIN BLOOD LEVEL; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOMAL INSTABILITY; GENDER; GENE ACTIVATION; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; HEPATITIS B VIRUS; HEPATITIS C; HIGH GRADE DYSPLASTIC NODULE; HISTOPATHOLOGY; HUMAN; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MACROREGENERATIVE NODULE; MICROVASCULARIZATION; ONCOGENE; PRECANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; TUMOR DIFFERENTIATION; TUMOR IMMUNITY; TUMOR VASCULARIZATION;

CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 49349109364     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn113     Document Type: Review

References (74)

1. Parkin,D.M. et al. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
2. El-Seragh,H.B. (2002) Hepatocellular carcinoma and hepatitis C in the United States. Hepatology, 36, S74-S83.
3. D'Errico,A. et al. (1996) Histogenesis of primary liver carcinomas: Strengths and weaknesses of cytokeratin profile and albumin mRNA detection. Hum. Pathol., 27, 599-604.
4. Yuen,M.F. et al. (2000) Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology, 31, 330-335.
5. Trevisani,F. et al. (2002) Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: Effects on cancer stage and patient survival (Italian Experience). Am. J. Gastroenterol., 97, 734-744.
6. Kiyosawa,K. et al. (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology, 12, 671-675.
7. McMahon,B.J. (2005) Epidemiology and natural history of hepatitis B. Semin. Liver Dis., 25, S3-S8.
8. Thorgeirsson,S.S. et al. (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet., 31, 339-346.
9. Branda,M. et al. (2006) Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma. Hepatology, 43, 891-902.
10. Pang,R. et al. (2006) Molecular pathways in hepatocellular carcinoma. Cancer Lett., 240, 157-169.
11. Kremsdorf,D. et al. (2006) Hepatitis B virus-related hepatocellular carcinoma: Paradigms for viral-related human carcinogenesis. Oncogene, 25, 3823-3833.
12. Levrero,M. (2006) Viral hepatitis and liver cancer: The case of hepatitis C. Oncogene, 25, 3838-3847.
13. Laurent-Puig,P. et al. (2006) Genetics of hepatocellular tumors. Oncogene, 25, 3778-3786.
14. Lemmer,E.R. et al. (2006) Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: The potential of gene expression profiling. Semin. Liver Dis., 26, 373-384.
15. Wurmbach,E. et al. (2007) Genome-wide molecular profiles of HCV-induced dysplasia and bepatocellular carcinoma. Hepatology, 45, 938-947.
16. Nakashima,O. et al. (1995) Pathomorphologic characteristics of small hepatocellular carcinoma: A special reference to small hepatocellular carcinoma with indistinct margins. Hepatology, 22, 101-105.
17. International Working Party. (1995) Terminology of nodular lesions of the liver. Hepatology, 22, 983-993.
18. Paradis,V. et al. (1998) Clonal analysis of macronodules in cirrhosis. Hepatology, 28, 953-958.
19. Borzio,M. et al. (1997) Ultrasonography-detected macroregenerative nodules in cirrhosis: A prospective study. Gastroenterology, 112, 1617-1623.
20. Borzio,M. et al. (2003) Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J. Hepatol., 39, 208-214.
21. Albrecht,T. et al. (2004) Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med., 25, 249-256.
22. Tajima,T. et al. (2002) Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. Am. J. Roentgenol., 178, 885-897.
23. Tomizawa,M. et al. (1995) Growth patterns and interstitial invasion of small hepatocellular carcinoma. Pathol. Int., 45 352-358.
24. Borzio,M. et al. (1995) Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: A prospective study. Gastroenterology, 108, 812-817.
25. Shibata,M. et al. (1998) Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection. Lancet, 351, 1773-1777.
26. Takayama,T. et al. (1998) Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology, 28, 1241-1246.
27. Bolondi,L. (2003) Screening for hepatocellular carcinoma in cirrhosis. J. Hepatol., 39, 1076-1084.
28. Katoh,H. et al. (2005) Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patients outcome. J. Hepatol., 43, 863-874.
29. Benvegnu,L. et al. (2001) Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. Gut, 48, 110-115.
30. Kojiro,M. (1998) Pathology of early HCC-progression from early to advanced. Hepatogastroenterology, 45, 1203-1205.
31. Bruix,J. et al. (2006) New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene, 25, 3848-3856.
32. Esnaola,N.F et al. (2002) Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J. Gastrointest. Surg., 6, 224-232.
33. Llovet,J.M. et al. (2005) Resection and liver transplantation for hepatocellular carcinoma. Semin. Liver Dis., 25, 181-200.
34. Sheu,J.C. et al. (1985) Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology, 89 259-266.
35. Ebara,M. et al. (1986) Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology, 90, 289-298.
36. Okazaki,N. et al. (1989) Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. A preliminary report. Cancer, 63, 2207-2210.
37. Barbara,L. et al. (1992) Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology, 16, 132-137.
38. Okada,S. et al. (1993) Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time. Hepatogastroenterology, 40, 311-315.
39. Cheng,S.J. et al. (2002) Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transpl., 8, 323-328.
40. Cucchetti,A. et al. (2005) Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis. J. Hepatol., 43, 310-316.
41. Edmondson,H.A. et al. (1954) Primary carcinoma of the liver. A study of 100 cases among 48,900 necroscopies. Cancer, 7, 462-503.
42. Trevisani,F. et al. (1995) Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and non cirrhotic Italian patients. Cancer, 75, 2220-2232.
43. Grigioni,W.F. et al. (1990) The capsule surrounding primary liver tumors: Where from its prognostic significance? Int. J. Cancer, 45, 637-643.
44. Poon,R.T. et al. (2002) Tumor microvessel density as a prqdictor of recurrence after resection of hepatocellular carcinoma: A prospective study. J. Clin. Oncol., 20, 1775-1785.
45. Kumada,T. et al. (1997) Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 25, 87-92.
46. CLIP Group (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: The Cancer of the Liver Italian Program (CLIP) investigators. Hepatology, 28, 751-755.
47. Yamashita,F. et al. (1996) Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas. Gastroenterology, 111, 996-1001.
48. Tada,T. et al. (2005) Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma. Liver Int., 25, 848-853.
49. Mann,C.D. et al. (2007) Prognostic molecular markers in hepatocellular carcinoma: A systematic review. Eur. J. Cancer, 43, 979-992.
50. Lee,J.S. et al. (2004) Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40, 667-676.
51. Villa,E. et al. (2000) Natural history of inoperable hepatocellular carcinoma: Estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology, 32, 233-238.
52. Ho,M.C. et al. (2007) Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma. Cancer Lett., 250, 237-249.
53. Lee,J.S. et al. (2006) A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat. Med., 12, 410-416.
54. Nishida,N. et al. (1992) Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int. J. Cancer, 51, 862-868.
55. Laurent-Puig,P. et al. (2001) Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology, 120, 1763-1773.
56. Roayaje,S. et al. (2004) Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis. Liver Transpl., 10, 534-540.
57. Puoti,M. et al. (2004) Hepatocellular carcinoma in HIV-infected patients: Epidemiological features, clinical presentation and outcome. AIDS, 18, 2285-2293.
58. Yin,X.Y. et al. (2003) Prognostic significances of tumor-infiltrating S-100 positive dendritic cells and lymphocytes in patients with hepatocellular carcinoma. Hepatogastroenterology, 50, 1281-1284.
59. Taketomi,A. et al. (1998) Natural killer cell activity in patients with hepatocellular carcinoma: A new prognostic indicator after hepatectomy. Cancer, 83, 58-63.
60. Fu,J. et al. (2007) Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology, 132, 2328-2339.
61. Tanaka,K. et al. (2000) Serum testosterone: Estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients. Cancer Res., 60, 5106-5110.
62. Falkson,G. et al. (1988) Prognostic factors for survival in hepatocellular carcinoma. Cancer Res., 48, 7314-7318.
63. Llovet,J.M. et al. (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials. Hepatology, 29, 62-67.
64. El-Serag,H.B. et al. (2001) Trends in survival patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology, 33, 62-65.
65. Collier,J.D. et al. (1994) Clinical features and prognosis of hepatocellular carcinoma in Britain in relation to age. Age Ageing 23, 22-27.
66. Pignata,S. et al. (2006) Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP). Crit. Rev. Oncol. Hematol., 59; 243-249.
67. Villa,E. et al. (2001) Hormonal therapy with megestrol in inoporable hepatocellular carcinoma characterized by variant oestrogen receptors. Br. J. Cancer, 85, 1606-1608.
68. Cantarini,M.C. et al. (2006) Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma. Am. J. Gastroenterol., 101, 91-98.
69. Nzeako,U.C. et al. (1996) Hepatocellular carcinoma in cirrhotic and non-cirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am. J. Clin. Pathol., 105, 65-75.
70. Bruix,J. et al. (2005) Management of hepatocellular carcinoma. Hepatology, 42, 1208-1236.
71. Nagasue,N. et al. (1984) The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer, 54, 1461-1465.
72. Sangiovanni,A. et al. (2004) Increased survival of cirrhotic patients with hepatocellular carcinoma detected during surveillance. Gastroenterology, 126, 1005-1014.
73. El-Serag,H.B. et al. (2006) Treatment and outcomes of treating hepatocellular carcinoma among medicate recipients in the United States: a population-based study. J. Hepatol., 340, 745-750.
74. Capocaccia,R. et al. (2007) Hepatocellular carcinoma: Trends of incidence and survival in Europe and the United States at the end of the 20th century. Am. J. Gastroenterol., 102, 1661-1670.